Please login to the form below

Not currently logged in
Email:
Password:

Dr Sotirios Stergiopoulos leaves Shire for Ipsen

He becomes the French biopharma’s chief medical officer

Sotirios StergiopoulosIpsen has promoted Dr Sotirios Stergiopoulos from global medical affairs to chief medical officer.

He first joined the French biopharma firm from Baxalta - now Shire - last year, where he served as vice president, head of global medical affairs oncology.

Prior to that, he has held roles including executive medical director, oncology, US medical affairs for Celgene and senior global brand medical director, oncology at Novartis.

He said: “This is an exciting time for Ipsen with significant growth and evolution and together with our experienced leadership team, I look forward to helping our company continue to bring innovative new medicines to our patients.”

Stergiopoulos, who has also previously served as director of medical affairs, oncology for Bayer, is a fellow at the American College of Physicians and a member of the Royal Society of Medicine in the UK.

His new role will see him report to Alexandre Lebeaut, executive vice-president R&D and chief scientific officer of Ipsen, who said: “Stergiopoulos has extensive experience in directing global medical affairs strategies and a strong expertise in oncology drug development that includes chemotherapy, immunology drugs and targeted agents across various tumour indications.

“We are delighted to appoint him to an expanded role through which he will make the voice of the patient heard at the highest levels of the organisation and represent the company externally as its primary medical representative.”

2nd February 2018

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Onyx Health Ltd

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...

Latest intelligence

Patient-centricity in improving patient recruitment advertising
This blog looks into the importance of concepts and patient centricity in patient recruitment....
AI and life sciences
AI: the smart money is on the smart thinking
Looking at the three key areas where AI is being applied: drug discovery, clinical decision-making and clinical trials...
Virtual Engagement At Porterhouse: Reflections on the past few months
A look at how the pitfalls of virtual engagement can be avoided and the key advantages of virtual client and KOL engagement strategies in a now predominantly digital world....

Infographics